Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Kim, Min Kyoung  [Clear All Filters]
2018
Lee G-W, Park SWoo, Go S-I, Kim H-G, Kim MKyoung, Min C-K, Kwak J-Y, Bae S-B, Yoon S-S, Lee J-J, et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.
2019
Kim H, Lee K-H, Sohn SKyun, Kim I, Kim S-H, Park Y, Choi JHye, Kwak J-Y, Kim MKyoung, Bae SHwa, et al. Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials. Acta Haematol. 2019:1-12.
2022
Yi JHo, Jeong SHyun, Kim SJin, Yoon DHyun, Kang HJin, Koh Y, Kim JSeok, Lee W-S, Yang D-H, Do YRok, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer Res Treat. 2022.
2023
Kim SJin, Jo J-C, Yoon DHyun, Yang D-H, Yoon SEun, Lee G-W, Kong JHyun, Park Y, Kang K-W, Lee H-S, et al. Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation. Front Oncol. 2023;13:1230629.
Cho H, Yoon DHyun, Shin D-Y, Koh Y, Yoon S-S, Kim SJin, Do YRok, Lee G-W, Kwak J-Y, Park Y, et al. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404). Cancer Res Treat. 2023.
Kim DJung, Jeong S, Kong SGim, Lee S, Lim S-N, Oh SYong, Do YRok, Lee WSik, Lee MHong, Bae SHwa, et al. Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea. Sci Rep. 2023;13(1):2551.